Ph.D. and Postdoctoral Fellow in Materials Science, University of Nottingham, UK

Focuses on research and investment in medical devices, new energy, and advanced materials

With 7 years of investment experience, has led multiple industrial investment, M&A, and buyout projects

Pharmacy Doctor, Fudan University,

Research and investment in the field of anti-tumor drugs,

Experiences in consulting and healthcare investment,

Overseas mergers and acquisitions & innovative drug investment

MSc of Biology, Sun Yat-Sen University, Focuses on gene, cell therapy, high-end medical device research and investment, many years of VC/PE investment experience, with > 15 successful investment cases, including 5 IPO projects

With over a decade of experience in financial management and capital operations across listed companies (Kingdee International, Wiscom System) and private equity funds. Holds a Bachelor's degree in Accounting. Deeply involved in investor relations, brand strategy, and post-investment exit management of core projects, driving diversified financing strategies and maximizing project value realization.

Master's degree in Investment from Central University of Finance and Economics, and serves as an off-campus graduate advisor. Over ten years of experience in biomedical investment, with backgrounds in the investment department of a listed pharmaceutical company and a central SOE private equity firm. Has led investments and incubations in over 20 projects across innovative drugs and medical devices, with more than 6 exits through IPOs, M&A, and equity transfers. Has initiated and established multiple healthcare funds.

Bachelor's degree in Pharmacy from Shanghai Jiao Tong University and Master's degree in Finance from Durham University, UK, with a multidisciplinary background. Five years of investment experience, specializing in medical devices and new materials. Successfully exited 4 investments, including 2 IPO projects.

Ph.D. in Chemistry from the University of Texas at Austin. Nearly ten years of experience in biomedical investment in both China and the United States. Specializes in investments in cutting-edge biotechnology fields such as innovative drugs and synthetic biology.